ClinicalTrials.gg
Drug

NPI 2358 clinical trials

Also written Plinabulin, NPI-2358 and BPI-2358.

studies test it
15
open now
2
in phase 3
4
first study started
2006

How each study uses NPI 2358 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the NPI 2358 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Development codes

NPI-2358
5
BPI-2358
2

Other names

Plinabulin
9

Studies by the year they started

15 studies that test it; most in 2017 (3)

Studies that test NPI 2358, by start year
YearStudies
20061
20081
20151
20161
20173
20182
20191
20212
20231
20241
20261

By phase

A phase 1/2 study counts in both.

Phase 1
6
Phase 2
9
Phase 3
4

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 8 · Other 7

BeyondSpring Pharmaceuticals Inc. (6) · Nereus Pharmaceuticals, Inc. (2) · Peking Union Medical College Hospital (1) · Memorial Sloan Kettering Cancer Center (1) · Salma Sabbour (1) · Lyudmila Bazhenova, M.D. (1) · Xiaorong Dong (1) · M.D. Anderson Cancer Center (1)

Often tested with

Tested in the same studies.

Docetaxel (1) · Pegfilgrastim (1) · Etoposide (1) · Platinum Compounds (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test NPI 2358.

Studies

Open first, then newest update. How each study uses NPI 2358 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 15

Codes

What other systems call NPI 2358 · ClinicalTrials.gg INT004981

  • MeSH (NLM) C514351NPI 2358One source ClinicalTrials.gov

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.